Renato D. Lopes
Renato D. Lopes
Professor afiliado da EPM/UNIFESP
E-mail confirmado em
Citado por
Citado por
Heart disease and stroke statistics—2012 update: a report from the American Heart Association
Writing Group Members, VL Roger, AS Go, DM Lloyd-Jones, EJ Benjamin, ...
Circulation 125 (1), e2-e220, 2012
Heart disease and stroke statistics—2017 update: a report from the American Heart Association
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ...
circulation 135 (10), e146-e603, 2017
Apixaban versus warfarin in patients with atrial fibrillation
CB Granger, JH Alexander, JJV McMurray, RD Lopes, EM Hylek, ...
New England Journal of Medicine 365 (11), 981-992, 2011
2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation Developed …
Authors/Task Force Members, AJ Camm, GYH Lip, R De Caterina, ...
European heart journal 33 (21), 2719-2747, 2012
Apixaban with antiplatelet therapy after acute coronary syndrome
JH Alexander, RD Lopes, S James, R Kilaru, Y He, P Mohan, DL Bhatt, ...
New England Journal of Medicine, 2011
Thrombin-receptor antagonist vorapaxar in acute coronary syndromes
P Tricoci, Z Huang, C Held, DJ Moliterno, PW Armstrong, F Van de Werf, ...
New England Journal of Medicine 366 (1), 20-33, 2012
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
AF Hernandez, JB Green, S Janmohamed, RB D'Agostino Sr, CB Granger, ...
The Lancet 392 (10157), 1519-1529, 2018
Hydroxychloroquine with or without azithromycin in mild-to-moderate Covid-19
AB Cavalcanti, FG Zampieri, RG Rosa, LCP Azevedo, VC Veiga, ...
New England Journal of Medicine 383 (21), 2041-2052, 2020
Mild or moderate Covid-19
RT Gandhi, JB Lynch, C Del Rio
New England Journal of Medicine 383 (18), 1757-1766, 2020
Initial invasive or conservative strategy for stable coronary disease
DJ Maron, JS Hochman, HR Reynolds, S Bangalore, SM O’Brien, ...
New England Journal of Medicine 382 (15), 1395-1407, 2020
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo …
PM Ridker, JG MacFadyen, T Thuren, BM Everett, P Libby, RJ Glynn, ...
The Lancet 390 (10105), 1833-1842, 2017
Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation
RD Lopes, G Heizer, R Aronson, AN Vora, T Massaro, R Mehran, ...
New England Journal of Medicine 380 (16), 1509-1524, 2019
Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial
SH Hohnloser, Z Hijazi, L Thomas, JH Alexander, J Amerena, M Hanna, ...
European heart journal 33 (22), 2821-2830, 2012
Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale
RD Lopes, JH Alexander, SM Al-Khatib, J Ansell, R Diaz, JD Easton, ...
American heart journal 159 (3), 331-339, 2010
Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial
BM Tomazini, IS Maia, AB Cavalcanti, O Berwanger, RG Rosa, VC Veiga, ...
Jama 324 (13), 1307-1316, 2020
Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in …
EM Hylek, C Held, JH Alexander, RD Lopes, R De Caterina, DM Wojdyla, ...
Journal of the American College of Cardiology 63 (20), 2141-2147, 2014
Search for a Higgs boson in the mass range from 145 to 1000 GeV decaying to a pair of W or Z bosons
V Khachatryan, AM Sirunyan, A Tumasyan, W Adam, E Asilar, T Bergauer, ...
Journal of High Energy Physics 2015 (10), 1-52, 2015
Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery
RD Lopes, GE Hafley, KB Allen, TB Ferguson, ED Peterson, ...
New England Journal of Medicine 361 (3), 235-244, 2009
The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study
Z Hijazi, J Oldgren, J Lindbäck, JH Alexander, SJ Connolly, ...
The Lancet 387 (10035), 2302-2311, 2016
Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial
S Halvorsen, D Atar, H Yang, R De Caterina, C Erol, D Garcia, ...
European heart journal 35 (28), 1864-1872, 2014
O sistema não pode executar a operação agora. Tente novamente mais tarde.
Artigos 1–20